BMO Capital Markets analyst Evan Seigerman said Pfizer’s discontinuation of its GLP-1 pill sends the company back to the starting block as its other obesity drugs are all in the early stages of ...

In an interview, the US pharmaceuticals giant’s international chief says Australia has made no progress in making life easier for medicine developers.

American journalist Megyn Kelly has claimed that she developed an autoimmune disorder after taking two doses of the Pfizer ...

The U.S. Food and Drug Administration on Monday warned consumers and pharmacies that fake versions of Ozempic, a drug to ...

The drugmaker said Tuesday that it would stop studying danuglipron after a participant in one of its trials experienced a ...

The drug manufacturer will no longer study and test danuglipron after a participant in a clinical trial was injured.

US stocks edged higher on Monday as investors focused on tech's temporary reprieve from President Trump's tariffs. But on Sunday, US Commerce Secretary Howard Lutnick said that those electronics would ...

UnitedHealthcare CEO Brian Thompson was shot to death in New York City on Dec. 4 as he was walking to an investor conference ...

Pfizer on Monday announced it is halting development of a daily weight loss pill after one patient experienced a liver injury ...

In a report released today, Akash Tewari from Jefferies maintained a Buy rating on Pfizer (PFE – Research Report), with a price target of ...

US stocks trimmed bigger early-session gains but rose steadily Monday, as investors focused on tech's temporary reprieve from ...